Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 1, Issue 2, 2004, Pages 98-105

  Friedman, Scott L ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cirrhosis; Extracellular matrix; Hepatic fibrosis; Matrix degradation; Stellate cell

Indexed keywords

ADIPONECTIN; ALDOSTERONE ANTAGONIST; ALPHA INTERFERON; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTHELMINTIC AGENT; ANTIFIBROTIC AGENT; ANTIOXIDANT; ANTIVIRUS AGENT; CASPASE INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN RECEPTOR ANTAGONIST; GLIOTOXIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1; NITRIC OXIDE DONOR; PENTOXIFYLLINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSCRIPTION FACTOR;

APOPTOSIS; DISEASE ASSOCIATION; DISEASE COURSE; FIBROGENESIS; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER SINUSOID; LYMPHOCYTE SUBPOPULATION; MOLECULAR MECHANICS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SCHISTOSOMIASIS; STELLATE CELL;

DISEASE PROGRESSION; HUMANS; LIVER CIRRHOSIS; SIGNAL TRANSDUCTION;

EID: 15244356690     PISSN: 17434378     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncpgasthep0055     Document Type: Review

References (56)

1. Friedman SL (2000) Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 275: 2247-2250
2. Schuppan D et al. (2001) Matrix as modulator of stellate cell and hepatic fibrogenesis. Semin Liver Dis 21: 351-372
3. Geerts A (2001) History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Semin Liver Dis 21: 311-335
4. Pinzani M and Marra F (2001) Cytokine receptors and signaling in hepatic stellate cells. Semin Liver Dis 21: 397-416
5. Rockey D (2003) Vascular mediators in the injured liver. Hepatology 37: 4-12
6. Kinnman N et al. (2003) The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis. Lab Invest 83: 163-173
7. Cassiman D et al. (2002) Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. J Hepatol 36: 200-209
8. Corpechot C et al. (2002) Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis. Hepatology 35: 1010-1021
9. Forbes SJ et al. (2004) A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology 126: 955-963
10. Magness ST et al. (2004) A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations. Hepatology 40: 1151-1159
11. Kalluri R and Neilson EG (2003) Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112: 1776-1784
12. Tsukamoto H (2002) Redox regulation of cytokine expression in Kupffer cells. Antioxid Redox Signal 4: 741-748
13. Bataller R et al. (2003) NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J Clin Invest 112: 1383-1394
14. Tuma DJ (2002) Role of malondialdehyde-acetaldehyde adducts in liver injury. Free Radic Biol Med 32: 303-308
15. Canbay A et al. (2003) Apoptotic body engulfment by a human stellate cell line is profibrogenic. Lab Invest 83: 655-663
16. Canbay A et a. (2002) Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis. Gastroenterology 123: 1323-1330
17. LeCouter J et al. (2003) Angiogenesis-independent endothelial protection of liver: role of VEGFR-1. Science 299: 890-893
18. Olaso E et al. (2003). Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis. Hepatology 37: 674-685
19. Marra F (2002) Chemokines in liver inflammation and fibrosis. Front Biosci 7: d1899-d1914
20. Yoshiji H et al. (2003).Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis. Gut 52: 1347-1354
21. Ankoma-Sey et al. (2000) Hypoxic stimulation of vascular endothelial growth factor expression in activated rat hepatic stellate cells. Hepatology 31: 141-148
22. Schwabe RF et al. (2003) Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration. Am J Physiol Gastrointest Liver Physiol 285: G949-G958
23. Bataller R et al. (2004) Hepatitis C virus core and nonstructural proteins induce fibrogenic effects in hepatic stellate cells. Gastroenterology 126: 529-540
24. Efsen E et al. (2002) Up-regulated expression of fractalkine and its receptor CX3CR1 during liver injury in humans. J Hepatol 37: 39-47
25. Paik YH et al. (2003) Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology 37: 1043-1055
26. Kobayashi S et al. (2003) Apoptosis of T cells in the hepatic fibrotic tissue of the rat: a possible inducing role of hepatic myofibroblast-like cells. Cell Tissue Res 311: 353-364
27. Shi Z et al. (1997) Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses. Proc Natl Acad Sci USA 94: 10663-10668
28. Hillebrandt S et al. (2002) Genome-wide analysis of hepatic fibrosis in inbred mice identifies the susceptibility locus Hfib1 on chromosome 15. Gastroenterology 123: 2041-2051
29. Safadi R et al. (2004) Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes. Gastroenterology 127: 870-882
30. Rachfal AW and Brigstock DR (2003) Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis. Hepatol Res 26: 1-9
31. Mann DA and Smart DE (2002) Transcriptional regulation of hepatic stellate cell activation. Gut 50: 891-896
32. Hellemans K et al. (2003) Peroxisome proliferator-activated receptor-beta signaling contributes to enhanced proliferation of hepatic stellate cells. Gastroenterology 124: 184-201
33. Marra F et al. (2000) Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells. Gastroenterology 119: 466-478
34. Miyahara T et al. (2000) Peroxisome proliferator-activated receptors and hepatic stellate cell activation. J Biol Chem 275: 35715-35722
35. Hellemans K et al. (2004) Differential modulation of rat hepatic stellate phenotype by natural and synthetic retinoids. Hepatology 39: 97-108
36. Kalinichenko VV et al. (2003) Foxf1 +/- mice exhibit defective stellate cell activation and abnormal liver regeneration following CCI4 injury. Hepatology 37: 107-117
37. Yang C et al. (2003) Liver fibrosis: insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors. Gastroenterology 124: 147-159
38. Bonacchi A et al. (2003) The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C. Gastroenterology 125: 1060-1076
39. Pohlmann S et al. (2003) Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. J Virol 77: 4070-4080
40. Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346: 1221-1031
41. Ikejima K et al. (2002) Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat. Gastroenterology 122: 1399-1410
42. Leclercq IA et al. (2002) Leptin is essential for the hepatic fibrogenic response to chronic liver injury. J Hepatol 37: 206-213
43. Saxena NK et al. (2003) Leptin induces increased alpha2(I) collagen gene expression in cultured rat hepatic stellate cells. J Cell Biochem 89: 311-320
44. Kamada Y et al. (2003) Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. Gastroenterology 125: 1796-1807
45. Bonis PA et al. (2001) Is liver fibrosis reversible? N Engl J Med 344: 452-454
46. Desmet VJ and Roskams T (2004) Cirrhosis reversal: a duel between dogma and myth. J Hepatol 40: 860-867
47. Poynard T et al. (2002) Impact of pegylated interferon alpha-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology 122: 1303-1313
48. Murphy FR et al. (2002) Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis. J Biol Chem 277: 11069-11076
49. Wanless IR et al. (2000) Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis. Arch Pathol Lab Med 124: 1599-1607
50. Issa R et al. (2004) Spontaneous recovery from micronodular cirrhosis: Evidence for incomplete resolution associated with matrix cross-linking. Gastroenterology 126: 1795-1808
51. Bataller R et al. (2003) Genetic polymorphisms and the progression of liver fibrosis: A critical appraisal. Hepatology 37: 493-503
52. Albanis E and Friedman SL (2002) Non-invasive markers of hepatic fibrosis. Clin Perspect Gastroenterol 5: 182-187
53. Callewaert N et al. (2004) Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics. Nat Med 10: 429-434
54. Pinzani M and Rombouts K (2004) Liver fibrosis: from the bench to clinical targets. Dig Liver Dis 36: 231-242
55. Schuppan D and Porov Y (2002) Hepatic fibrosis: From bench to bedside. J Gastroenterol Hepatol 17 (Suppl 3): S300-S305
56. Friedman SL and Arthur MJP (2002) Reversing hepatic fibrosis. Sci Med 8: 194-205